Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Mac Cana brings the remarkable story of a Fermanagh doctor responsible for curing a type of cancer to the IMC in Enniskillen.

Shares of Tempus AI (TEM) are rising 5% in pre-market trading after surging 13% yesterday. The healthcare-focused AI stock ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. | Otsuka has broken up with a clutch of clinical ...

Former Nickerson basketball star Ava Jones is speaking out about her cancer diagnosis months after a man was sentenced to ...

WICHITA, Kan. (KSNW) – Over the weekend, Ava Jones announced on Instagram that he had been diagnosed with cancer. On Thursday, Ava told KSN that she has Stage 4 Hodgkin’s Lymphoma. Coming up at 10, ...

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...

A few students involved in the Leukemia and Lymphoma Society sit down with FOX43 to talk about the organization and future ...